Response to Comments: MolDX: HLA-DQB1*06:02

CGS Administrators received no public comments during the open comment period (11/16/2016–01/03/2017) for the draft MolDX policy on HLA-DQB1*06:02 testing for narcolepsy. No coverage criteria, changes, or decisions are documented in this response-to-comments record.